Updates: 30.03.2021 16:34
Released: 30.03.2021, 16:34
Berlin – Berlin, Munich and Brandenburg have announced that they will stop vaccinating people under the age of 60 with AstraZeneca’s covid-19 vaccine. This was stated by local authorities. An extraordinary meeting will be held tonight with the participation of Chancellor Angela Merkel, representatives of the Federal Ministry of Health and the individual German states on the next steps with a preparation from the British-Swedish consortium. There have been several cases of cerebral venous thrombosis in Germany after vaccination with this substance, but no association with the vaccine has been established.
Berlin senator responsible for health care Dilek Kalayci said that the ban on vaccinating people under the age of 60 with a product from AstraZeneka is preventive. Berlin wants the opinion on the preparation to be prepared by experts from the Paul Ehrlich Institute (PEI), which acts as a drug regulator in Germany.
A doctor from the prestigious Berlin Charité clinic, Leif Erik Sander, wrote on Twitter that there were 31 cases of cerebral venous thrombosis in Germany, among 2.7 million vaccinated with the company’s vaccine. “It is a rare but very serious complication,” he said.
Referring to preliminary documents from the Standing Vaccination Commission (Stiko), the DPA states that the covid-19 vaccine will be “generally” recommended in Germany for people over 60 years of age. Use for persons below this age will be possible after “assessment by a physician, individual risk acceptance and thorough explanation”. The Standing Vaccination Commission operates at the Robert Koch Institute.
Germany temporarily suspended AstraZenka immunization in mid-March due to suspected cases of cerebral venous thrombosis, but resumed vaccination after a few days following a positive conclusion from the European Medicines Agency (EMA), which was examining the side effects of the medicine. Several other European countries did the same.